TherapeuticsMD, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $63.1M | — |
| FY2016 | — | $127.5M | $131.5M |
| FY2017 | — | $129.9M | $127.1M |
| FY2018 | $73.4M | $97.5M | $161.6M |
| FY2019 | $194.6M | $9.2M | $160.8M |
| FY2020 | $237.7M | $-124.0M | $80.5M |
| FY2021 | $0 | $-93.6M | $64.9M |
| FY2022 | — | $35.1M | $49.3M |
| FY2023 | — | $29.3M | $4.3M |
| FY2024 | — | $27.4M | $5.1M |